S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q3 2025

Adar1 Capital Management

Period: Q3 2025 Β· Filed: 2025-11-14
View on SEC EDGAR β†—
AUM
$1.06B
Total portfolio value
Positions
217
Reported securities
Top Holding
ABVX
10.8% $114.7M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ABVXABIVAX SA$114.7M10.77%$84.90$144.65+70.4%
10.8%
KROSKEROS THERAPEUTICS INC$85.3M8.01%$15.82$11.26-28.8%
8.0%
PTGXPROTAGONIST THERAPEUTICS INC$65.7M6.17%$66.43$131.62+98.1%
6.2%
ROIVROIVANT SCIENCES LTD$50.6M4.76%$15.13$35.13+132.2%
4.8%
BOXXEA SERIES TRUST$38.4M3.61%$113.86$117.22+3.0%
3.6%
SPYSPDR S&P 500 ETF TR$36.4M3.42%$660.71$744.78+12.7%
3.4%
IMVTIMMUNOVANT INC$36.1M3.39%$16.12$38.79+140.6%
3.4%
ETNB89BIO INC$31.1M2.92%β€”β€”
2.9%
SPYPUTSPDR S&P 500 ETF TR$30.3M2.85%$660.71$744.78+12.7%
2.9%
ZLABZAI LAB LTD$29.4M2.77%$33.89$19.12-43.6%
2.8%
CYTKCYTOKINETICS INC$28.5M2.68%$54.96$86.49+57.4%
2.7%
SEPNSEPTERNA INC$22.1M2.08%$18.81$34.00+80.8%
2.1%
PRTAPROTHENA CORP PLC$14.3M1.35%$9.76$9.69-0.7%
1.4%
BBIOBRIDGEBIO PHARMA INC$14.2M1.33%$51.94$77.19+48.6%
1.3%
ABUSARBUTUS BIOPHARMA CORP$13.2M1.24%$4.54$4.87+7.3%
1.2%
RAPTRAPT THERAPEUTICS INC$13.1M1.23%β€”β€”
1.2%
CTMXCYTOMX THERAPEUTICS INC$12.9M1.21%$3.19$3.82+19.8%
1.2%
BILSPDR SERIES TRUST$12.4M1.17%$89.20$91.44+2.5%
1.2%
AMLXAMYLYX PHARMACEUTICALS INC$11.8M1.11%$13.59$18.27+34.4%
1.1%
QURECALLUNIQURE NV$11.7M1.10%$58.37$41.81-28.4%
1.1%
BIOABIOAGE LABS INC$11.1M1.04%$5.88$25.10+326.9%
1.0%
MNPRMONOPAR THERAPEUTICS INC$10.6M1.00%$81.67$97.79+19.7%
1.0%
CRNXCRINETICS PHARMACEUTICALS IN$10.3M0.97%$41.65$42.23+1.4%
1.0%
LXEOLEXEO THERAPEUTICS INC$10.2M0.96%$6.64$4.69-29.4%
1.0%
CGONCG ONCOLOGY INC$10.0M0.94%$40.28$70.36+74.7%
0.9%
TSHATAYSHA GENE THERAPIES INC$9.3M0.87%$3.27$6.53+99.7%
0.9%
REGNREGENERON PHARMACEUTICALS$8.8M0.83%$560.05$654.27+16.8%
0.8%
IONSIONIS PHARMACEUTICALS INC$8.8M0.82%$65.42$81.80+25.0%
0.8%
JANXJANUX THERAPEUTICS INC$8.6M0.81%$24.44$15.54-36.4%
0.8%
IKTINHIBIKASE THERAPEUTICS INC$8.5M0.80%$1.62$1.99+22.8%
0.8%

Quarter-on-Quarter Activity

Q3 2025 vs. Q2 2025

New Positions (8)

TickerIssuerNotionalSince Filing
QUREUNIQURE NV$11.7M-28.4%
IVVDINVIVYD INC$8.1M
MTSRMETSERA INC$8.0M
EQEQUILLIUM INC$8.0M
QUREUNIQURE NV$7.8M-28.4%
BBOTBRIDGEBIO ONCOLOGY THERAPEUT$5.8M
ATAIATAI LIFE SCIENCES NV$4.8M
UTHRUNITED THERAPEUTICS CORP DEL$4.7M

Exited Positions (8)

TickerIssuerNotional
SAGESAGE THERAPEUTICS INC$6.6M
VERVVERVE THERAPEUTICS INC$5.3M
HLXBHELIX ACQUISITION CORP II$4.7M
SHYISHARES TR$4.4M
ARDXARDELYX INC$3.6M
THRDTHIRD HARMONIC BIO INC$3.4M
ALECALECTOR INC$2.4M
CRMDCORMEDIX INC$2.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
REPLCALLREPLIMUNE GROUP INC$4.0M+9312.4%
ASNDASCENDIS PHARMA A/S$7.0M+2492.4%
LXEOLEXEO THERAPEUTICS INC$9.6M+955.7%-29.4%
SMMTSUMMIT THERAPEUTICS INC$1.9M+758.1%
SNYSANOFI SA$3.0M+642.1%
FULCCALLFULCRUM THERAPEUTICS INC$2.8M+540.3%
SRPTSAREPTA THERAPEUTICS INC$5.8M+536.0%
JANXJANUX THERAPEUTICS INC$7.1M+465.4%-36.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
BRIDGEBIO PHARMA INC$0.3M-99.0%
BRIDGEBIO PHARMA INC$0.3M-99.0%
OVIDOVID THERAPEUTICS INC$-0.0M-88.9%
ORKAORUKA THERAPEUTICS INC$-1.2M-85.4%
CNTACENTESSA PHARMACEUTICALS PLC$-2.6M-81.9%
AKROAKERO THERAPEUTICS INC$-1.5M-81.5%
GOSSCALLGOSSAMER BIO INC$-0.1M-75.8%
MLYSMINERALYS THERAPEUTICS INC$-1.1M-74.1%
← Back to Hedge Funds